Expression and function of G-protein-coupled receptors in the male reproductive tract

Anais da Academia Brasileira de Ciencias

Volumn 81, Issue 3, 2009, Pages 321-344

  Avellar, Maria Christina W ^a   Lázari, Maria Fatima M ^a   Porto, Catarina S ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Male reproductive tract; Muscarinic acetylcholine receptors; Relaxin receptors; 1 adrenoceptor

Indexed keywords

RATTUS;

EID: 70349333800     PISSN: 00013765     EISSN: 16782690     Source Type: Journal    
DOI: 10.1590/S0001-37652009000300002     Document Type: Review

References (265)

1. 1-adrenoceptor mediating contractions in the rat aorta, vas deferens and spleen. Br J Pharmacol 109: 80-87.
2. Alonso-Llamazares A, López-Alonso J, Del Barrio M, Casanova E, Calvo P and Chinchetru M. 1998. Cloning of chicken and mouse alpha 1b adrenergic receptor. Biochim Biophys Acta 1396: 263-266.
3. Anand-Ivell RJ, Relan V, Balvers M, Coiffec-Dorval I, Fritsch M, Bathgate RA and Ivell R. 2006. Expression of the insulin-like peptide 3 (INSL3) hormone-receptor (LGR8) system in the testis. Biol Reprod 74: 945-953.
4. Anderson MB, Collado-Torres M and Vaupel MR. 1986. Absence of relaxin immunostaining in the male reproductive tracts of the rat and mouse. J Histochem Cytochem 7: 945-948.
5. Ban Y, Sato T, Nakatsuka T, Kemi M, Samura K, Matsumoto H, Cukierski MA and van Zwieten MJ. 2002. Impairment of male fertility induced by muscarinic receptor antagonists in rats. Reprod Toxicol 16: 757-765.
6. Bathgate RA et al. 2002. Human relaxina gene 3 (H3) and the equivalent mouse relaxin (M3) gene. J Biol Chem 277: 1148-1157.
7. Bathgate RA, Ivell R, Sanborn BM, Sherwood OD and Summers RJ. 2006. International union of pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev 58: 7-31.
8. Bernard V, Levey AI and Bloch B. 1999. Regulation of the subcellular distribution of m4 muscarinic acetylcholine receptors in striatal neurons in vivo by the cholinergic environment: evidence for regulation of cell surface receptors by endogenous and exogenous stimulation. J Neurosci 19: 10237-10249.
9. Bernard V, Brana C, Liste I, Lockridge O and Bloch B. 2003. Dramatic depletion of cell surface m2 muscarinic receptor due to limited delivery from intracytoplasmic stores in neurons of acetylcholinesterase-deficient mice. Mol Cell Neurosci 23: 121-133.
10. Bhathal PS, Gerkens JF and Mashford ML. 1974. Spermatic granuloma of the epididymis in rats treated with guanethidine. J Pathol 112: 19-26.
11. Birdsall NJ and Lazareno S. 2005. Allosterism at muscarinic receptors: ligands and mechanisms. Mini Rev Med Chem 5: 523-543.
12. Bishop MJ. 2007. Recent advances in the discovery of alpha1-adrenoceptor agonists. Curr Top Med Chem 7: 135-145.
13. Blanco M and Robinson MJ. 2004. Muscarinic M3 acetylcholine receptor immunostaining in paraffin-embedded normal and neoplastic prostatic gland tissue. Ann Diagn Pathol 8: 333-336.
14. Bogic L, Madel M and Bryant-Greenwood GD. 1995. Relaxin gene expression in human reproductive tissues by in situ hybridization. J Clin Endocrinol Metabol 80: 130-137.
15. Borges MOR, Abreu MLC, Porto CS and Avellar MC. 2001. Characterization of muscarinic acethylcholine receptor in rat Sertoli cells. Endocrinology 142: 4701-4710.
16. Braddon SA. 1978. Relaxin-dependent adenosine 3',5'-monophosphate concentration changes in the mouse pubic symphysis. Endocrinology 102: 1292-1299.
17. Brodde OE and Leineweber K. 2004. Autonomic receptor systems in the failing and aging human heart: similarities and differences. Eur J Pharmacol 500: 167-176.
18. Burazin TC, Bathgate RAD, Macris M, Layfiels S, Gundlach AL and Tregear GW. 2002. Restricted but abundant expression of the novel rat gene-3 (R3) relaxin in the dorsal tegmental region of brain. J Neurochem 82: 1553-1557.
19. Burt RP, Chapple CR and Marshall I. 1995. Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen. Br J Pharmacol 115: 467-475.
20. 2+ influx stimulated by diacylglycerol and PKC. Br J Pharmacol 123: 317-325.
21. Campos M, Morais PL and Pupo AS. 2003. Effects of castration and of testosterone replacement on alpha1-adrenoceptor subtypes in the rat vas deferens. Eur J Pharmacol 471: 149-156.
22. Caulfield MP and Birdsall NJM. 1998. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50: 279-290.
23. Chalothorn D, McCune DF, Edelmann SE, Garcia-Cazarin ML, Tsujimoto G and Piascik MT. 2002. Differences in the cellular localization and agonist-mediated internalization properties of the alpha(1)-adrenoceptor subtypes. Mol Pharmacol 61: 1008-1016.
24. - conductances. Biol Reprod 51: 1040-1045.
25. 1A-adrenoceptor isoforms. FEBS Lett 422: 279-283.
26. Chaturapanich G, Maythaarttaphong S, Verawatnapakul V and Pholpramool C. 2002. Mediation of contraction in rat cauda epididymidis by alpha-adrenoceptors. Reproduction 124: 887-892.
27. Cheah SH and Sherwood OD. 1980. Target tissues for relaxin in the rat: tissue distribution of injected 125I-labeled relaxin and tissue changes in adenosine 3',5'-monophosphate levels after in vitro relaxin incubation. Endocrinology 106: 1203-1209.
28. Chen S, Lin F, Iismaa S, Lee KN, Birckbichler PJ and Graham RM. 1996. Alpha1-adrenergic receptor signalling via Gh is subtype specific and independent of its transglutaminase activity. J Biol Chem 271: 32385-32391.
29. Chen S, Xu M, Lin F, Lee D, Riek P and Graham RM. 1999. Phe310 in transmembrane VI of the alpha1B- adrenergic receptor is a key switch residue involved in activation and catecholamine ring aromatic bonding. J Biol Chem 274: 16320-16330.
30. 1A-adrenoceptors. Biochem J 343: 231-239.
31. Da Silva MC, Gimeno MF and Gimeno AL. 1975. Physiologic and pharmacologic studies on the motility of isolated guinea-pig cauda epididymidis. Fertil Steril 26: 1250-1256.
32. Daly CJ, Milligan CM, Milligan G, Mackenzie JF and McGrath JC. 1998. Cellular localization and pharmacological characterization of functioning alpha-1 adrenoceptors by fluorescent ligand binding and image analysis reveals identical binding properties of clustered and diffuse populations of receptors. J Pharmacol Exp Ther 286: 984-990.
33. 1L-adrenoceptor pharmacology in functional studies. Eur J Pharmacol 370: 337-343.
34. Davenport CW and Heindel JJ. 1987. Cholinergic inhibition of cAMP accumulation in Sertoli cells cultured from immature hamsters. J Androl 8: 307-313.
35. Debruyne FM. 2000. Alpha blockers: are all created equal? Urology 56: 20-22.
36. 1D-adrenoceptor subtype in rat myocardium, aorta and other tissues. Br J Pharmacol 119: 269-276.
37. Diviani D, Lattion AL, Abuin L, Staub O and Cotecchia S. 2003. The adaptor complex 2 directly interacts with the alpha 1b-adrenergic receptor and plays a role in receptor endocytosis. J Biol Chem 278: 19331-19340.
38. Docherty JR. 1998. Subtypes of functional alpha1- and alpha2-adrenoceptors. Eur J Pharmacol 361: 1-15.
39. Docherty JR. 2002. Age-related changes in adrenergic neuro effector transmission. Auton Neurosci 96: 8-12.
40. Doggrell SA. 1986. M1 and M2-muscarinic receptors in the epididymal half of the rat vas deferens. GenPharmacol 17: 239-241.
41. Du JY, Zuo WL, Chen MH, Xiang H and Zhou WL. 2006. Involvement of muscarinic acetylcholine receptors in chloride secretion by cultured rat epididymal epithelium. Cell Biol Int 30: 741-746.
42. Eglen RM. 2006. Muscarinic receptor subtype in neuronal and non-neuronal cholinergic function. 2006. Auton Autacoid Pharmacol 6: 219-233.
43. Eglen RM, Adham N and Whiting RL. 1992. Acute desensitization of muscarinic receptors in the isolated guinea-pig ileal longitudinal muscle. J Auton Pharmacol 12: 137-148.
44. Ehrén I, Sjöstrand NO, Hammarström M and Wiklund NP. 1997. Is glandular formation of nitric oxide a prerequisite for muscarinic secretion of fructose in the guinea-pig seminal vesicle? Urol Res 25: 433-438.
45. Eisenhofer G. 2001. The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 91: 35-62.
46. Errasti AE, Avellar MCW, Daray FM, Tramontano J, Luciani LI, Lina Bard MJ, Marostica E and Rothlin RP. 2003. Human umbilical vein vasoconstriction induced by epinephrine acting on alpha1B-adrenoceptor subtype. Am J Obstet Gynecol 189: 1472-1480.
47. Esbenshade TA, Hirasawa A, Tsujimoto G, Tanaka T, Yano J, Minneman KP and Murphy TJ. 1995. Cloning of the human alpha 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N- MC cells. Mol Pharmacol 47: 977-985.
48. Essig M, Schoenfeld C, Amelar RD, Dubin L and Weiss G. 1982. Stimulation of human sperm motility by relaxin. Fertil Steril 38: 339-343.
49. Feng S, Bogatcheva NV, Kamat AA, Truong A and Agoulnik AI. 2006. Endocrine effects of relaxin over-expression in mice. Endocrinology 147: 407-414.
50. Fevold HL, Hisaw FL and Meyer RK. 1930. The relaxative hormone of the corpus luteum. Its purification and concentration. J Am Chem Soc 52: 3340-3348.
51. Filonzi M, Cardoso LC, Pimenta MT, Queiróz DB, Avellar MC, Porto CS and Lazari MF. 2007. Relaxin family peptide receptors Rxfp1 and Rxfp2: mapping of the mRNA and protein distribution in the reproductive tract of the male rat. Reprod Biol Endocrinol 5: 29.
52. 1A adrenoceptors in human prostate: implications for adrenoceptor classification. Mol Pharmacol 49: 209-215.
53. Ford APDW, Daniels DV, Chang DJ, Gever JR, Jasper JR, Lernick JD and Clarke DE. 1997. Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification. Br J Pharmacol 121: 1127-1135.
54. Forray C, Bard JA, Wetzel JM, Chiu G, Shapiro E, Tang R, Lepor H, Hartig PR, Weinshank RL and Branchek TA. 1994. The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype. Mol Pharmacol 45: 703-708.
55. Fukasawa R, Taniguchi N, Moriyama N, Ukai Y, Yamazaki S, Ueki T, Kameyama S, Kimura K and Kawabe K. 1998. The alpha1L-adrenoceptor subtype in the lower urinary tract: a comparison of human urethra and prostate. Br J Urol 82: 733-737.
56. Gao B and Kunos G. 1993. Isolation and characterization of the gene encoding the rat alpha 1B adrenergic receptor. Gene 131: 243-247.
57. Gao B and Kunos G. 1994. Transcription of the rat alpha 1B adrenergic receptor gene in liver is controlled by three promoters. J Biol Chem 269: 15762-15767.
58. Gobeil F Jr, Fortier A, Zhu T, Bossolasco M, Leduc M, Grandbois M, Heveker N, Bkaily G, Chemtob S and Barbaz D. 2006. G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm. Can J Physiol Pharmacol 84: 287-297.
59. 1a adrenoceptor. Eur J Pharmacol 426: 147-155.
60. 1-adrenergic receptor subtypes: molecular structure, function and signalling. Circ Res 78: 737-749.
61. Grimm U, Fuder H, Moser U, Bumert HG, Mutschler E and Lambrecht G. 1994. Characterization of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in rabbit isolated vas deferens. Naunyn Schmiedebergs Arch Pharmacol 349: 1-10.
62. Gunnersen JM, Crawfor RJ and Tregear GW. 1995. Expression of the relaxin gene in rat tissues. Mol Cell Endocrinol 10: 55-64.
63. Gunnersen JM, Fu P, Roche PJ and Tregear GW. 1996. Expression of human relaxin genes: characterization of a novel alternatively-spliced human relaxin mRNA species. Mol Cell Endocrinol 118: 85-94.
64. Haag C, Berkels R, Gründemann D, Lazar A, Taubert D and Schomig E. 2004. The localisation of the extraneuronal monoamine transporter (EMT) in rat brain. J Neurochem 88: 291-297.
65. Hague C, Uberti MA, Chen Z, Hall RA and Minneman KP. 2004a. Cell surface expression of alpha1D- adrenergic receptors is controlled by heterodimerization with alpha1B-adrenergic receptors. J Biol Chem 279: 15541-15549.
66. Hague C, Chen Z, Pupo AS, Schulte N, Toews ML and Minneman K. 2004b. The N-terminus of the human {alpha}1D-adrenergic receptor prevents cell surface expression. J Pharmacol Exp Ther 309: 388-397.
67. Halls ML, Bond CP, Sudo S, Kumagai J, Ferraro T, Layfield S, Bathgate RA and Summers RJ. 2005. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8). J Pharmacol Exp Ther 313: 677-687.
68. Halls ML, Bathgate RAD and Summers RJ. 2006. Relaxin family peptide receptors, RXFP1 and RXFP2, modulate cyclic AMP signalling by distinct mechanisms. Mol Pharmacol 70: 214-226.
69. Halls ML, van der Westhuizen ET, Bathgate RAD and Summers RJ. 2007. Relaxin family peptide receptors - former orphans reunite with their parent ligands to activate multiple signalling pathways. Br J Pharmacol 150: 677-691.
70. Hamamura M, Maróstica E, Avellar MCW and Porto CS. 2006. Muscarinic acetylcholine receptor subtypes in the rat seminal vesicle. Mol Cell Endocrinol 247: 192-198.
71. Hanft G and Gross G. 1989. Subclassification of alpha 1- adrenoceptor recognition sites by urapidil derivatives and other selective antagonists. Br J Pharmacol 97: 691-700.
72. Hansell DJ, Bryant-Greenwood GD and Greenwood FC. 1991. Related Expression of the human relaxin H1 gene in the decidua, trophoblast, and prostate. J Clin Endocrinol Metab 72: 899-904.
73. Hauser F, Nothacker HP and Grimmelikhuijzen CJ. 1997. Molecular cloning, genomic organization and developmental regulation of a novel receptor from Drosophila melanogaster structurally related to members of the thyroid-stimulating hormone, follicle-stimulating hormone, luteinizing hormone/choriogonadotropin receptor family from mammals. J Biol Chem 272: 1002-1010.
74. Hawrylyshyn KA, Michelotti GA, Cogé F, Guenin SP and Schwinn DA. 2004. Update on human alpha1-adrenoceptor subtype signalling and genomic organization. Trends Pharmacol Sci 25: 449-455.
75. Hein P and Michel MC. 2007. Signal transduction and regulation: are all alpha1-adrenergic receptor subtypes created equal? Biochem Pharmacol 73: 1097-1106.
76. Hib J. 1976. Effects of autonomic drugs on epididymal contractions. Fertil Steril 27: 951-956.
77. Hib J and Caldeyro-Barcia R. 1974. Neurohormonal control of epididymal contractions. In: Coutinho EM and Fuchs F (Eds), Physiology and Genetic of Reproduction, PartB,NewYork, PlenumPress, p.111.
78. Hieble JP and Ruffolo RR Jr. 1996. The use of alpha-adrenoceptor antagonists in the pharmacological management of benign prostatic hypertrophy: an overview. Pharmacol Res 33: 145-160.
79. Hieble JP, Bylund DB, Clarke DE, Eikenburg DC, Langer SZ, Lefkowitz RJ, Minneman KP and Ruffolo RR Jr. 1995. International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol Rev 47: 267-270.
80. Hirasawa A, Shibata K, Horie K, Takey Y, Obika K, Tanaka T, Muramoto N, Takagaki K, Yano J and Tsujimoto G. 1995. Cloning, functional expression and tissue distribution of human alpha 1C-adrenoceptor splice variants. FEBS Lett 363: 256-260.
81. Hirasawa A, Sugawara T, Awaji T, Tsumaya K, Ito H and Tsujimoto G. 1997. Subtype-specific differences in subcellular localization of alpha1-adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface alpha1-adrenoceptors irrespective of the subtype. Mol Pharmacol 52: 764-770.
82. Hirasawa A, Awaji T, Xu Z, Shinoura H and Tsujimoto G. 2001. Regulation of subcellular localization of alpha1-adrenoceptor subtypes. Life Sci 68: 2259-2267.
83. Hisaw FL. 1926. Experimental relaxation of the pubic ligament of the guinea pig. Proc Soc Exp Biol Med 23: 661-663.
84. Homma Y, Hamada K, Nakayama Y, Tsujimoto G and Kawabe K. 2000. Effects of castration on contraction and alpha(1)-adrenoceptor expression in rat prostate. Br J Pharmacol 131: 1454-1460.
85. Horie K, Obika K, Foglar R and Tsujimoto G. 1995. Selectivity of the imidazoline alpha-adrenoceptor agonists (oxymetazoline and cirazoline) for human cloned alpha 1- adrenoceptor subtypes. Br J Pharmacol 116: 1611-1618.
86. 1-adrenoceptors on vascular smooth muscle: correlation with the regulation of contraction. J Pharmacol Exp Ther 290: 452-463.
87. Hsu SY, Kudo M, Chen T, Nakabayashi K, Bhalla A, van der Spek PJ, van Duin M and Hsueh AJ. 2000. The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signalling mechanism for LGR7. Mol Endocrinol 14: 1257-1271.
88. Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD and Hsueh AJ. 2002. Activation of orphan receptors by the hormone relaxin. Science 295: 671-674.
89. Hu K and Nattel S. 1995. Mechanisms of ischemic preconditioning in rat hearts. Involvement of alpha 1B-adrenoceptors, pertussis toxin-sensitive Gproteins, and protein kinase C. Circulation 92: 2259-2265.
90. Huleihel M and Lunenfeld E. 2004. Regulation of spermatogenesis by paracrine/autocrine testicular factors. Asian J Androl 6: 259-268.
91. Hulme EC, Birdsall NJM and Buckley NJ. 1990. Muscarinic receptor subtypes. Ann Rev Pharmacol Toxicol 30: 633-673.
92. Hwa J and Perez DM. 1996. The unique nature of the serine interactions for alpha 1-adrenergic receptor agonist binding and activation. J Biol Chem 271: 6322-6327.
93. Hwa J, Graham RM and Perez DM. 1995. Identification of critical determinants of alpha 1-adrenergic receptor subtype selective agonist binding. J Biol Chem 270: 23189-23195.
94. Hwa J, Graham RM and Perez DM. 1996. Chimeras of alpha1-adrenergic receptor subtypes identify critical residues that modulate active state isomerization. J Biol Chem 271: 7956-7964.
95. Ii M, Yamamoto H, Adachi Y, Maruyama Y and Shinomura Y. 2006. Role of metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med 231: 20-27.
96. Iram S and Hoyle CH. 2005. Potentiation of sympathetic neuromuscular transmission mediated by muscarinic receptors in guinea pig isolated vas deferens. Naunyn Schmiedebergs Arch Pharmacol 371: 212-220.
97. Ivell R and Einspanier A. 2002. Relaxin peptides are new global players. Trends Endocrinol Metab 13: 343-348.
98. Ivell R, Hunt N, Khan-Dawood F and Dawood MY. 1989. Expression of the human relaxin gene in the corpus luteum of the menstrual cycle and in the prostate. Mol Cell Endocrinol 66: 251-255.
99. Jackson VM and Cunnane TC. 2001. Neurotransmitter release mechanisms in sympathetic neurons: past, present, and future perspectives. Neurochem Res 26: 875-889.
100. Jeyabalan A, Novak J, Danielson LA, Kerchner LJ, Opett SL and Conrad KP. 2003. Essential role for vascular myogenic reactivity of small arteries. Circ Res 93: 1249-1257.
101. Jeyabalan A, Novak J, Doty KD, Matthews J, Fisher MC, Kerchner LJ and Conrad KP. 2007. Vascular matrix metalloproteinase-9 mediates the inhibition of myogenic reactivity in small arteries isolated from rats after short term administration of relaxin. Endocrinology 148: 189-197.
102. Jiang X, Dreano M, Buckler DR, Cheng S, Ythier A, Wu H, HendricksonWA., and ElTayar N. 1995. Structural predictions for the ligand-binding region of glycoprotein hormone receptors and the nature of hormone-receptor interactions. Structure 3: 1341-1353.
103. Jockenhovel F, Altensell A., and Nieschlag E. 1990. Active immunization with relaxin does not influence objectively determined sperm motility in rabbits. Andrologia 22: 171-178.
104. Judson DG, Pay S and Bhoola KD. 1980. Modulationof cyclic AMP in isolated rat uterine tissue slices by porcine relaxin. J Endocrinol 87: 153-159.
105. Jurkiewicz NH, Caricati-Neto A, Verde LF, Avellar MCW, Reuter HR and Jurkiewicz A. 2006. Sympathetic neurotransmission in the rat testicular capsule: functional characterization and identification of mRNA encoding alpha1-adrenoceptor subtypes. Eur J Pharmacol 43: 141-150.
106. Kamat AA, Feng S, Bogatcheva NV, Truong A, Bishop CE and Agoulnik AI. 2004. Genetic targeting of relaxin and insulin-like factor 3 receptors in mice. Endocrinology 145: 4712-4720.
107. Karkanias GB, Ansonoff MA and Etgen AM. 1996. Estradiol regulation of alpha 1b-adrenoceptor mRNA in female rat hypothalamus-preoptic area. J Neuroendocrinol 8: 449-455.
108. Kern A, Agoulnik AI and Bryant-Greenwood GD. 2007. The low-density lipoprotein class A module of the relaxin receptor (leucine-rich repeat containing G-protein coupled receptor 7): its role in signalling and trafficking to the cell membrane. Endocrinology 148: 1181-1194.
109. 2+ releasefrom intracellular stores in rat prostate neuroendocrine cells. J Korean Med Sci 20: 256-261.
110. Kinghorn EM, Bate AS and Higgins SJ. 1987. Growth of rat seminal vesicle epithelial cells in culture: neurotransmitters are required for androgen-regulated synthesis of tissue-specific secretory proteins. Endocrinology 121: 1678-1688.
111. Kohsaka T, Takahara H, Sasada H, Kawarasaki T, Bamba K, Masaki J and Tagami S. 1992. Evidence for immunoreactive relaxin in boar seminal vesicles using combined light and electron microscope immunocyto-chemistry. J Reprod Fertil 95: 397-408.
112. Kondo S, Tashima Y and Morita T. 1994. Segmental differences in the density of autonomic receptors in dog vas deferens. Urol Int 53: 62-67.
113. Krajnc-Franken MA, van Disseldorp AJ, Koenders JE, Mosselman S, van Duin M and Gossen JA. 2004. Impaired nipple development and parturition in LGR7 knockout mice. Mol Cell Biol 24: 687-696.
114. Kubo T, Fukuda K, Mikami A, Maeda A, Takahashi H, Mishina M, Haga T, Haga K, Ichiyama A and Kangawa K. 1986. Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetyl-choline receptor. Nature 323: 411-416.
115. Kudo M, Chen T, Nakabayashi K, Hsu SY and Hsueh AJW. 2000. The nematode leucine-rich repeat-containing, G protein-coupled receptor LGR protein homologous to vertebrate gonadotropin and thyrotropin receptors is constitutively activated in mammalian cells. Mol Endocrinol 14: 272-284.
116. Lacey JP, Donatucci CF, Price DT, Page SO, Bennett SA, Tenniswood MP and Schwinn DA. 1996. Effects of androgen deprivation on prostate alpha 1-adrenergic receptors. Urology 48: 335-341.
117. Langer S. 1999. History and nomenclature of alpha 1 adrenoceptors. Eur Urol 36: 2-6.
118. Lanzafame AA, Christopoulos A and Mitchelson F. 2003. Cellular signalling mechanism for muscarinic acetylcholine receptors. Receptor Channel 9: 241-260.
119. Lau WA and Pennefather JN. 1998. Muscarinic receptor subtypes in the rat prostate gland. Eur J Pharmacol 343: 151-156.
120. Laz TM, Forray C, Smith KE, Bard JA, Vaysse PJ, Branchek TA and Weinshank RL. 1994. The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype. Mol Pharmacol 46: 414-422.
121. Leeb-Lundberg LM, Cotecchia S, Lomasney JW, DeBernardis JF, Lefkowitz RJ and Caron MG. 1985. Phorbol esters promote alpha 1-adrenergic receptor phosphorylation and receptor uncoupling from inositol phospholipid metabolism. Proc Natl Acad Sci USA 82: 5651-5655.
122. Lefkowitz RJ. 1998. G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signalling and desensitization. J Biol Chem 273: 18677-18680.
123. Lefkowitz RJ and Caron MG. 1988. Adrenergic receptors. Models for the study of receptors coupled to guanine nucleotide regulatory proteins. J Biol Chem 263: 4993-4996.
124. Lefkowitz RJ, Pitcher J, Krueger K and Daaka Y. 1998. Mechanisms of beta-adrenergic receptor desensitization and resensitization. Adv Pharmacol 42: 416-420.
125. Lenhart JA, Ryan PL, Ohleth KM, Palmer SS and Bagnell CA. 2001. Relaxin increases secretion of matrix metalloproteinase-2 and matrix metalloproteinase-9 during uterine and cervical growth and remodeling in the pig. Endocrinology 142: 3941-3949.
126. Lepor H, Zhang W, Kobayashi S, Tang R, Wang B and Shapiro E. 1994. A comparison of the binding and functional properties of alpha-1 adrenoceptors and area density of smooth muscle in the human, canine and rat prostates. J Pharmacol Exp Ther 270: 722-727.
127. Leung AYH, Yip WK and Wong PYD. 1992. Characterization of adrenoceptors involved in the electrogenic chloride secretion by cultured rat epididymal epithelium. Br J Pharmacol 107: 146-151.
128. Liu C, Eriste E, Sutton S, Chen J, Roland B, Kuei C, Farmer N, Jörnvall H, Sillard R and Lovenberg TW. 2003. Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135. J Biol Chem 278: 50754-50764.
129. Lockwood DH and Williams-Ashman HG. 1971. Cholinergic-stimulated alkaline phosphatase secretion and phospholipid synthesis in guinea pig seminal vesicles. J Cell Physiol 77: 7-15.
130. Longhurst PA and Brotcke TP. 1989. Effects of castration and diabetes mellitus on cholinergic responsiveness and muscarinic receptors in the rat vas deferens. J Urol 141: 1225-1229.
131. Lopez-Gimenez JF, Canals M, Pediani JD and Milligan G. 2007. The alpha1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function. Mol Pharmacol 71: 1015-1029.
132. Lucas TFG, Avellar MCW and Porto CS. 2004. Effects of carbachol on rat Sertoli cell proliferation and muscarinic acetylcholine receptors regulation: an in vitro study. Life Sci 75: 1761-1773.
133. Lucas TFG, Siu ER, Royer C, Trindade CS, Nader HB, Lazari MFM and Porto CS. 2008. Muscarinic acetylcholine receptors: relevance to infertility and male contraception. Immun, Endoc & Metab, Agents in Med Chem 8: 42-50.
134. Luthin GR, Wang P, Zhou H, Dhanasekaran D and Ruggieri MR. 1997. Role of m1 receptor-G protein coupling in cell proliferation in the prostate. Life Sci 60: 963-968.
135. MacDonald A and McGrath JC. 1980. The effects of castration on neurotransmission in the rat vas deferens. Br J Pharmacol 69: 49-58.
136. 1-adrenoceptor ligand-binding sites. J Pharmacol Exp Ther 294: 434-443.
137. MacKinnon AC, Spedding M and Brown CM. 1994. Alpha 2-adrenoceptors: more subtypes but fewer functional differences. Trends Pharmacol Sci 15: 119-123.
138. Mallard NJ, Marshall RW, Sithers AJ and Spriggs TL. 1992. Separation of putative alpha 1A- and alpha 1B-adrenoceptor mediated components in the tension response of the rat vas deferens to electrical field stimulation. Br J Pharmacol 105: 727-731.
139. Manni L, Holmang A, Lundeberg T, Aloe L and Stener-Victorin E. 2005. Ovarian expression of alpha (1)- and beta (2)-adrenoceptors and p75 neurotrophin receptors in rats with steroid-induced polycystic ovaries. Auton Neurosci 118:79-87.
140. Manni L, Holmang A, Cajander S, Lundeberg T, Aloe L and Stener-Victorin E. 2006. Effect of anti-NGF on ovarian expression of alpha1- and beta2- adrenoceptors, TrkA, p75NTR, and tyrosine hydroxylase inratswithsteroid-inducedpolycysticovaries. AmJPhysiol Regul Integr Comp Physiol 290: R826-R835.
141. Markus RP and Avellar MCW. 1997. Age-related changes in the reactivity of postsynaptic adrenoceptors in the rat vas deferens: differences between the epididymal and prostatic portion. Auton Pharmacol 17: 147-154.
142. Maróstica E, Guaze EF, Avellar MCW and Porto CS. 2001. Characterization of muscarinic acetylcholine receptors in rat epididymis. Biol Reprod 65: 1120-1126.
143. Maróstica E, Avellar MCW and Porto CS. 2005. Effects of testosterone on muscarinic acetylcholine receptors in the rat epididymis. Life Sci 77: 656-669.
144. 1D-adrenoceptors by agonists and inverse agonists. Mol Pharmacol 57: 659-666.
145. McCune SK and Hill JM. 1995. Ontogenic expression of two alpha-1 adrenergic receptor subtypes in the rat brain. J Mol Neurosci 6: 51-62.
146. Mendes FR, Hamamura M, Queiróz DB, Porto CS and Avellar MCW. 2004. Effects of androgen manipulation on alpha1-adrenoceptor subtypes in the rat seminal vesicle. Life Sci 75: 1449-1463.
147. Michelotti GA, Price DT and Schwinn DA. 2000. Alpha 1 adrenergic receptor regulation: basic science and clinical implications. Pharmacol Ther 88: 281-309.
148. Michelotti GA, Bauman MJ, Smith MP and Schwinn DA. 2003. Cloning and characterization of the rat alpha 1a-adrenergic receptor gene promoter. Demonstration of cell specificity and regulation by hypoxia. J Biol Chem 278: 8693-8705.
149. Miranda HF, Bustamante D, Castillo O, Salvatierra P, Saavedra H, Fernandez E, Paeile C, Pelissier T and Pinardi G. 1992. Cholinergic receptors in the human vas deferens. J Recept Res 12: 101-115.
150. Miranda HF, Duran E, Bustamante D, Paeile C and Pinardi G. 1994. Pre- and postjunctional muscarinic receptor subtypes in the vas deferens of rat. Gen Pharmacol 25: 1643-1647.
151. Miranda HF, Duran E, Fernandez E and Pinardi G. 1995. Muscarinic receptor subtypes in the bisected vas deferens of the rat. Gen Pharmac 26: 387-391.
152. Mookerjee I, Unemori EN, Du XJ, Tregear GW and Samuel CS. 2005. Relaxin modulates fibroblast function, collagen production and matrix metalloproteinase-2 expression by cardiac fibroblasts. Ann NY Acad Sci 1041: 190-193.
153. Moriyama N, Kurimoto S, Horie S, Nasu K, Tanaka T, Yano K, Hirano H, Tsujimoto G and Kawabe K. 1996. Detection of alpha 1-adrenoceptor subtypes in human hypertrophied prostate by in situ hybridization. Histochem J 28: 283-288.
154. 3H]prazosin binding. Mol Pharmacol 29: 321-330.
155. 1-adrenoceptor subtypes in the human prostate: functional and binding studies. Br J Urol 74: 572-578.
156. + channel. Circ Res 80: 370-376.
157. Nadelhaft I. 2003. Cholinergic axons in the rat prostate and neurons in the pelvic ganglion. Brain Res 989: 52-57.
158. Nakaoka H, Perez DM, Baek KJ, Das T, Husain A, Misono K, Im MJ and Graham RM. 1994. Gh: a GTP-binding protein with transglutaminase activity and receptor signalling function. Science 264: 1593-1596.
159. 1-adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non-hypertrophied tissue. Br J Pharmacol 119: 797-803.
160. Nasu K, Moriyama N, Fukasawa R, Tsujimoto G, Tanaka T, Yano J and Kawabe K. 1998. Quantification and distribution of alpha1-adrenoceptor subtype mR- NAs in human proximal urethra. Br J Pharmacol 123: 1289-1293.
161. Newinger J, Jockenhovel F and Nieschlag E. 1990. The influence of relaxin on motility of human sperm in vitro. Andrologia 22: 335-339.
162. Nishi S, Hsu SY, Zell K and Hsueh AJW.2000. Characterization of two fly LGR (Leucine-Rich Repeat-containing, G protein-coupled receptor) proteins homologous to vertebrate glycoprotein hormone receptors: constitutive activation of wild-type fly LGR1 but not LGR2 in transfected mammalian cells. Endocrinology 141: 4081-4090.
163. Nothacker HP and Grimmelikhuijzen CJP. 1993. Molecular cloning of a novel putative G protein-coupled receptor from sea anemones structurally related to members of the FSH, TSH, LH/CG receptor family from mammals. Biochem Biophys Res Commun 197: 1062-1069.
164. Obara K, Arai K, Miyajima N, Hatano A, Tomita Y and Takahashi K. 2000. Expression of m2 muscarinic acetylcholinereceptor mRNAinprimary cultureofhuman prostate stromal cells. Urol Res 28: 196-200.
165. Papatsoris AG, Karamouzis MV and Papavassiliou AG. 2007. The power and promise of "rewiring" the mitogen-activated protein kinase network in prostate cancer therapeutics. Mol Cancer Ther 6: 811-819.
166. Patrão MT, Queiróz DB, Lázari MF and Avellar MCW. 2008. Cloning, expression and immunolocalization of alpha1-adrenoceptor in different tissues from rhesus monkey and human male reproductive tract. Mol Hum Reprod 14: 85-96.
167. 1a adrenergicreceptor using homology modeling and molecular docking. Biochem Biophys Res Commun 319: 493-500.
168. Perez DM, Piascik MT, Malik N, Gaivin R and Graham RM. 1994. Identification of the mRNA for the novel alpha 1D-adrenoceptor and two other alpha 1- adrenoceptors in vascular smooth muscle. Mol Pharmacol 46: 823-831.
169. Petitti N, Karkanas GB and Etgen AM. 1992. Estradiol selectivity regulates alpha 1B-noradrenergic receptors in the hypothalamus and preoptic area. J Neurosci 12: 3869-3876.
170. Piascik MT and Perez DM. 2001. Alpha1-adrenergic receptors: new insights and directions. J Pharmacol Exp Ther 298: 403-410.
171. Piascik MT, Guarino RD, Smith MS, Soltis EE, Saussy DL and Perez DM. 1995. The specific contribution of the novel alpha-1D adrenoceptor to the contraction of vascular smooth muscle. J Pharmacol Exp Ther 275: 1583-1589.
172. Piascik MT, Hrometz SL, Edelmann SE, Guarino RD, Hadley RW and Brown RD. 1997. Immunocytochemical localization of the alpha-1B adrenergic receptor and the contribution of this and the other subtypes to vascular smooth muscle contraction: analysis with selective ligands and antisense oligonucleotides. J Pharmacol Exp Ther 283: 854-868.
173. Pontari MA, Luthin GR, Braverman AS and Ruggieri MR. 1998. Characterization of muscarinic cholinergic receptor subtypes in rat prostate. J Recept Signal Transduct Res 18: 151-166.
174. Porter JE, Hwa J and Perez DM. 1996. Activation of the alpha1b-adrenergic receptor is initiated by disruption of an interhelical salt bridge constraint. J Biol Chem 271: 28318-28323.
175. Prenzel N, Zwick E, Daub H, Lesere M, Abraham R, Wallasch C and Ulrich A. 1999. EGF receptor transactivation by G-protein-couple receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402: 884-888.
176. Price DT, Chari RS, Berkowitz DE, Meyers WC and Schwinn DA. 1994a. Expression of alpha 1-adrenergic receptor subtype mRNA in rat tissues and human SK-N- MC neuronal cells: implications for alpha 1-adrenergic receptor subtype classification. Mol Pharmacol 46: 221-226.
177. Price DT, Lefkowitz RJ, Caron MG, Berkowitz D and Schwinn DA. 1994b. Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: implications for human alpha-adrenergic physiology. Mol Pharmacol 45: 171-175.
178. Price RR, Morris DP, Biswas G, Smith MP and Schwinn DA. 2002. Acute agonist-mediated desensitization of the human alpha 1a-adrenergic receptor is primarily independent of carboxyl terminus regulation: implications for regulation of alpha 1a-AR splice variants. J Biol Chem 277: 9570-9579.
179. 1-adrenoceptors in rat vas deferens. Eur J Pharmacol 351: 217-223.
180. Pupo AS and Minneman KP. 2003. Specific interactions between gC1qR and alpha1-adrenoceptor subtypes. J Recept Signal Transduct Res 23: 185-195.
181. Queiróz DB, Porto CS, Grossman G, Petrusz P and Avellar MCW. 2008. Immunolocalization of alpha(1A)-adrenoceptors in rat and human epididymis. Cell Tissue Res 332: 509-522.
182. Queiróz DBC, Mendes FR, Porto CS and Avellar MCW. 2002. Alpha1-adrenoceptor subtypes in rat epididymis and the effects of sexual maturation. Biol Reprod 66: 508-515.
183. Quesada A and Etgen AM. 2002. Functional interactions between estrogen and insulin-like growth factor-1 in the regulation of alpha1B-adrenoceptors and female reproductive function. J Neuroscience 22: 2401-2408.
184. Ramarao CS, Denker JM, Perez DM, Gaivin RJ, Riek RP and Graham RM. 1992. Genomic organization and expression of the human alpha 1B-adrenergic receptor. J Biol Chem 267: 21936-21945.
185. Ramsay D, Carr IC, Pediani J, Lopez-Gimenez JF, Thurlow R, Fidock M and Milligan G. 2004. High-affinity interactions between human alpha1A-adrenoceptor C-terminal splice variants produce homoand heterodimers but do not generate the alpha1L-adrenoceptor. Mol Pharmacol 66: 228-239.
186. Ratnasooriya WD and Wadsworth RM. 1990. Impairment of fertility of male rats with prazosin. Contraception 41: 441-447.
187. 1 adrenoceptor antagonist, inhibits fertility of male rats. Andrologia 26: 107-110.
188. Rayford W, Noble MJ, Austenfeld MA, Weigel J, Mebust WK and Shah GV. 1997. Muscarinic cholinergic receptors promote growth of human prostate cancer cells. Prostate 30: 160-166.
189. Ricker DD, Chamness SL, Hinton BT and Chang TSK. 1996. Changes in luminal fluid protein composition in the rat cauda epididymidis following partial sympathetic denervation. J Androl 17: 117-126.
190. Roehrborn CG and Schwinn DA. 2004. Alpha-1 adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia. J Urol 171: 1029-1035.
191. 1D. Biochem Biophys Res Commun 200: 1177-1184.
192. Rokosh DG, Stewart AF, Chang KC, Bailey BA, Karliner JS, Camacho SA, Long CS and Simpson PC. 1996. Alpha1-adrenergic receptor subtype mRNAs are differentially regulated by alpha1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. Repression of alpha1B and alpha1D but induction of alpha1C. J Biol Chem 271: 5839-5843.
193. Rudner XL, Berkowitz DE, Booth JV, Funk BL, Cozart KL, D'Amico EB, El-Moalem H, Page SO, Richardson CD and Winters B. 1999. Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age. Circulation 100: 2336-2343.
194. Ruffolo RR Jr and Hieble JP. 1999. Adrenoceptor pharmacology: urogenital applications. Eur Urol 36: 17-22.
195. Ruggieri MR, Colton MD, Wang P, Smyth RJ, Pontari MA and Luthin GR. 1995. Human prostate muscarinic receptor subtypes. J Pharmacol Exp Ther 274: 976-982.
196. Salamanca AE, Siemasko KF, Diebold Y, Calonge M, Gao J, Juárez-Campo M and Stern ME. 2005. Expression of muscarinic and adrenergic receptors in normal human conjunctival epithelium. Invest Ophthalmol Vis Sci 46: 504-513.
197. Sallés J and Badia A. 1991. Mechanisms underlying the differential sensitivity to alpha 1-adrenoceptor activation in the bisected rat vas deferens. Br J Pharmacol 102: 439-445.
198. Samuel CS, Tian H, Zhao L and Amento EP. 2003a. Relaxin is a key mediator of prostate growth and male reproductive tract development. Lab Invest 83: 1055-1067.
199. Samuel CS, Zhao C, Bathgate RA, Bond CP, Parry LJ, Summers RJ, Tang ML, Amento EP and Tregear GW. 2003b. Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis. FASEB J 17: 121-123.
200. Samuel CS, Zhao C, Bathgate RAD, Du XJ, Summers RJ, Amento EP, Walker LL, McBurnie M, Zhao L and Tregear GW. 2005. The relaxin gene- knockout mouse: a model of progressive fibrosis. Ann NY Acad Sci 1041: 173-181.
201. Sanbe A, Tanaka Y, Fujiwara Y, Tsumura H, Yamauchi J, Cotecchia S, Koike K, Tsujimoto G and Tanoue A. 2007. Alpha-1 adrenoceptor is required for normal male sexual function. Br J Pharmacol 52: 332-340.
202. Sanborn BM, Kuo HS, Weisbrodt NW and Sherwood OD. 1980. The interaction of relaxin with the rat uterus. I. Effect on cyclic nucleotide levels and spontaneous contractile activity. Endocrinology 106: 1210-1215.
203. Sarosi P, Schoenfeld C, Berman J, Basch R, Randolph G, Amelar R, Dubin L, Steinetz BG and Weiss G. 1983. Effectofanti-relaxinantiserumonsperm motility in vitro. Endocrinology 112: 1860-1861.
204. Sato T, Ban Y, Uchida M, Gondo E, Yamamoto M, Sekiguchi Y, Sakaue A, Kemi M and Nakatsuka T. 2005. Atropine-induced inhibition of sperm and semen transport impairs fertility in male rats. J Toxicol Sci 30: 207-212.
205. Saussy DL Jr, Goetz AS, Queen KL, King HK, Lutz MW and Rimele TJ. 1996. Struture activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype. J Pharmacol Exp Ther 278: 136-144.
206. Sawutz DG, Lanier SM, Warren CD and Graham RM. 1987. Glycosylation of the mammalian alpha 1-adrenergic receptor by complex type N-linked oligosaccharides. Mol Pharmacol 32: 565-571.
207. Scarparo AC, Sumida DH, Patrão MTCC, Avellar MCW, Visconti MA and Castrucci MA. 2004. Catecholamine effects on human melanoma cells evoked by alpha1-adrenoceptors. Arch Dermatol Res 296: 112-119.
208. Schwinn DA and Kwatra MM. 1998. Expression and regulation of alpha 1-adrenergic receptors in human tissues. Adv Pharmacol 42: 390-394.
209. Schwinn DA, Lomasney JW, Lorenz W, Szklut PJ, Fremeau RT, Yang-Feng TL, Caron MG, Lefkowitz RJ and Cotecchia S. 1990. Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype. J Biol Chem 265: 8183-8189.
210. Scofield MA, Liu F, Abel PW and Jeffries WB. 1995. Quantification of steady state expression of mRNA for alpha-1 adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction. J Pharmacol Exp Ther 275: 1035-1042.
211. Scott DJ, Layfield S, Reisewijk A, Morita H, Tregear GW and Bathgate RAD. 2005. Characterisation of the mouse and rat relaxin receptors. Ann NY Acad Sci 1041: 8-12.
212. Scott DJ, Layfield S, Yan Y, Sudo S, Hsueh AJ, Tregear GW and Bathgate RA. 2006. Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signalling is mediated by their unique low density lipoprotein class A modules. J Biol Chem 281: 34942-34954.
213. Shannon HE, Sawyer BD, Bemis KG, Bymaster FP, Health I, Mitch CH and Ward JS. 1993. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens. Eur J Pharmacol 232: 47-57.
214. Shapiro E, Miller AR and Lepor H. 1985. Down-regulation of the muscarinic cholinergic receptor of the rat prostate following castration. J Urol 134: 179-182.
215. 1-adrenoceptor subtype proteins in different tissues of neonatal and adult rats. Can J Physiol Pharmacol 78: 237-243.
216. Sherwood OD. 2004. Relaxin's physiological roles and other diverse actions. Endocrine Rev 25: 205-234.
217. Shima S. 1992. Effects of androgen on α- and β-adrenergic receptors in membranes from the rat seminal vesicle. Biochim Biophys Acta 1175: 123-127.
218. Shinoura H, Shibata K, Hirasawa A, Tanoue A, Hashimoto K and Tsujimoto G. 2002. Key amino acids for differential coupling of alpha1-adrenergic receptor subtypes to Gs. Biochem Biophys Res Comm 299: 142-147.
219. 1-adrenoceptors in rat seminal vesicle. Eur J Pharmacol 381: 141-149.
220. Siu ER, Yasuhara F, Maróstica E, Avellar MCW and Porto CS. 2006. Expression and localization of muscarinic acetylcholine receptor subtypes in the rat efferent ductules and epididymis. Cell Tissue Res 323: 157-166.
221. Skinner MK. 2005. Sertoli cell secreted regulatory factors. In: Skinner MK and Griswold MD (Eds), Sertoli Cell Biology, Elsevier Science, San Diego, USA, p. 107-120.
222. Sokol RZ, Wang XS, Lechago J, Johnston PD and Swerdloff RS. 1989. Immunohistochemical localization of relaxin in human prostate. J Histochem 37: 1253-1255.
223. Steinetz BG, Schwabe C, Callard IP and Goldsmith LT. 1998. Dogfish shark (Squalus acanthias) testes contain a relaxin. J Androl 19: 110-115.
224. Sudo S, Kumagai J, Nishi S, Layfield S, Ferraro T, Bathgate RA and Hsueh AJ. 2003. H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2. J Biol Chem 278: 7855-7862.
225. Sugawara T, Hirasawa A, Hashimoto K and Tsujimoto G. 2002. Differences in the subcellular localization of alpha1-adrenoceptor subtypes can affect the subtype selectivity of drugs in a study with the fluorescent ligand BODIPY FL-prazosin. Life Sci 70: 2113-2124.
226. 1a adrenoceptor in rabbit. Br J Pharmacol 129: 1569-1576.
227. 1-adrenoceptors in human peripheral blood lymphocytes. J Auton Pharmacol 20: 305-312.
228. Teng CM, Guh JH and Ko FN. 1994. Functional identification of alpha1-adrenoceptor subtypes in human prostate: comparison with those in rat vas deferens and spleen. Eur J Pharmacol 265: 61-66.
229. Tensen CP, Van Kesteren ER, Planta RJ, Cox KJ, Burke JF, van Heerikhuizen H and Vreugdenhil E. 1994. A G protein-coupled receptor with low density lipoprotein-binding motifs suggests a role for lipoproteins in G-linked signal transduction. Proc Natl Acad Sci USA 91: 4816-4820.
230. Testa R, Guarneri L, Taddei C, Poggesi E, Angelico P, Sartani A, Leonardi A, Gofrit ON, Meretyk Sand Caine M. 1996. Functional antagonistic activity of Rec 15/2739, a novel alpha-1 antagonist selective for the lower urinary tract, on noradrenaline-induced contraction of human prostate and mesenteric artery. J Pharmacol Exp Ther 277: 1237-1246.
231. 2+ entry mediated by TRPC3/TRPC6 proteins in rat prostate smooth muscle (PS1) cell line. J Cell Physiol 204: 320-328.
232. Theroux TL, Esbenshade TA, Peavy RD and Minneman KP. 1996. Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. Mol Pharmacol 50: 1376-1387.
233. Toews ML, Prinster SC and Schulte NA. 2003. Regulation of alpha-1B adrenergic receptor localization, trafficking, function, and stability. Life Sci 74: 379-389.
234. Uberti MA, Hall RA and Minneman KP. 2003. Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmacological properties. Mol Pharmacol 64: 1379-1390.
235. Uberti MA, Hague C, Oller H, Minneman KP and Hall RA. 2005. Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors. J Pharmacol Exp Ther 313: 16-23.
236. van Dijk MM, de la Rosette JJ and Michel MC.2006. Effects of alpha(1)-adrenoceptor antagonists on male sexual function. Drugs 66: 287-301.
237. van Koppen CJ and Kaiser B. 2003. Regulation of muscarinic acetylcholine receptor signalling. Pharmacol Ther 98: 197-220.
238. Varma DR and Deng XF. 2000. Cardiovascular alpha 1 adrenoceptor subtypes: functions and signalling. Can J Physiol Pharmacol 78: 267-292.
239. Vázquez-Prado J, Medina LC, Romero-Avila MT, Gonzalez-Espinosa C and Garcia-Sainz JA. 2000. Norepinephrine- and phorbol ester-induced phosphorylation of alpha(1a)-adrenergic receptors. Functional aspects. J Biol Chem 275: 6553-6559.
240. Ventura S, Pennefather J and Mitchelson F. 2002. Cholinergic innervation and function in the prostate gland. Pharmacol Ther 94: 93-112.
241. 1-adrenergic receptor subtypes. J Pharmacol Exp Ther 302: 58-65.
242. 3H]prazosin binding to assess altered responsiveness of alpha1-adrenoceptors in the vas deferens of spontaneously hypertensive rat. Naunyn Schmiedebergs Arch Pharmacol 356: 383-391.
243. 1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate. J Urol 161: 635-640.
244. Walker WH and Cheng J. 2005. FSH and testosterone signalling in Sertoli cells. Reproduction 130: 15-28.
245. Wang JM, McKenna KE and Lee C. 1991. Determination of prostatic secretion in rats: effect of neurotransmitters and testosterone. Prostate 18: 289-301.
246. 2+ signalling by binding the N-terminal domain of RGS2 and the third intracellular loop of G-protein-coupled receptors. NatCell Biol 7: 405-411.
247. Waugh DJ, Zhao MM, Zuscik MJ and Perez DM. 2000. Novel aromatic residues in transmembrane domains IV and V involved in agonist binding at alpha(1a)-adrenergic receptors. J Biol Chem 275: 11698-11705.
248. Wess J. 2004. Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu Rev Pharmaco Toxicol 44: 423-450.
249. Wier WG and Morgan KG. 2003. Alpha1-adrenergic signalling mechanisms in contraction of resistance arteries. Rev Phys Biochem Pharmacol 150: 91-139.
250. Xiao L and Jeffries WB. 1998. Kinetics of alkylation of cloned rat alpha1-adrenoceptor subtypes by chloroethylclonidine. Eur J Pharmacol 347: 319-327.
251. Xu Z, Hirasawa A, Shinoura H and Tsujimoto G. 1999. Interaction of the alpha(1B)-adrenergic receptor with gC1q-R, a multifunctional protein. J Biol Chem 274: 21149-21154.
252. Yan HH, Mruk DD, Lee WM and Cheng CY. 2007. Ectoplasmic specialization: a friend or a foe of spermatogenesis? Bioessays 29: 36-48.
253. Yang M, Verfürth F, Büscher R and Michel MC. 1997. Is alpha1D-adrenoceptor protein detectable in rat tissues? Naunyn Schmiedebergs Arch Pharmacol 355: 438-446.
254. Yang-Feng TL, Xue FY, Zhong WW, Cotecchia S, Frielle T, Caron MG, Lefkowitz RJ and Francke U. 1990. Chromosomal organization of adrenergic receptor genes. Proc Natl Acad Sci USA 87: 1516-1520.
255. Yang-Feng TL, Han H, Lomasney JW and Caron MG. 1994. Localization of the cDNA for an alpha 1-adrenergic receptor subtype (ADRA1D) to chromosome band 20p13. Cytogenet Cell Genet 66: 170-171.
256. Yasuoka A, Abe K, Arai S and Emori Y. 1996. Molecular cloning and functional expression of the alpha1A- adrenoceptor of Medaka fish, Oryzias latipes. Eur J Biochem 235: 501-507.
257. Yazawa H and Honda K. 1993. Alpha 1-adrenoceptor subtype in the rat prostate is preferentially the alpha 1A type. Jpn J Pharmacol 62: 297-304.
258. Yazawa H, Saita Y, Iida E, Honma Y, Morita T and Honda K. 1994. Characterization of muscarinic cholinoceptor in primary culture of smooth muscle cells from human prostate. J Urol 152: 2173-2177.
259. Yki-Jarvinen H, Wahlstrom T and Seppala M. 1983. Immunohistochemical demonstration of relaxin in the genital tract of men. J Reprod Fertil 69: 693-695.
260. Yoshinaga T, Zhang S, Niidome T, Hiraoka M and Hirana Y. 1999. Potentiation of recombinant L-type Ca channel currents by alpha1-adrenoceptors coexpressed in baby hamster kidney (BHK) cells. Life Sci 64: 1643-1651.
261. Zhao L, Roche PJ, Gunnersen JM, Hammond VE, Tregear GW, Wintour EM and Beck F. 1999. Mice without a functional relaxin gene are unable to deliver milk to their pups. Endocrinology 140: 445-453.
262. Zhong H and Minneman K. 1999. alpha 1 adrenoceptor subtypes. Eur J Pharmacol 375: 261-276.
263. Zhong H, Lee D, Robeva A and Minneman KP. 2001. Signalling pathways activated by alpha1-adrenergic receptor subtypes in PC12 cells. Life Sci 68: 2269-2276.
264. Zimmermann S, Steding G, Emmen JM, Brinkmann AO, Nayernia K, Hostein AF, Engel W and Adham IM. 1999. Targeted disruption of the INsl3 gene causes bilateral cryptorchidism. Mol Endocrinol 13: 681-691.
265. Zuscik MJ, Piascik MT and Perez DM. 1999. Cloning, cell-type specificity, and regulatory function of the mouse alpha(1B)-adrenergic receptor promoter. Mol Pharmacol 56: 1288-1297.